ACAD
ACADIA Pharmaceuticals Inc.NASDAQHealthcare$22.20-0.54%ClosedMarket Cap: $3.78B
As of 2026-04-06
Insider Statistics (Q1 2026)
Purchases
24
Sales
18
Buy/Sell Ratio
1.33
Total Bought
$0.00
Total Sold
$10.00
Recent Insider Trades
| Filing Date | Name | Type | Action | Shares | Price | Shares After |
|---|---|---|---|---|---|---|
| Thu Mar 26 | Rhodes Jennifer J | officer: EVP, CHIEF LEGAL OFFICER, SEC | Sell | 3,844 | $21.47 | 11,280 |
| Thu Mar 26 | Thompson Elizabeth H.Z. | officer: EVP, Head of Research & Dev | Sell | 6,715 | $0.00 | 20,146 |
| Thu Mar 26 | Rhodes Jennifer J | officer: EVP, CHIEF LEGAL OFFICER, SEC | Sell | 7,515 | $0.00 | 22,547 |
| Thu Mar 26 | Owen Adams Catherine | director, officer: Chief Executive Officer | Sell | 23,509 | $0.00 | 70,530 |
| Thu Mar 26 | Owen Adams Catherine | director, officer: Chief Executive Officer | Sell | 11,641 | $21.47 | 14,803 |
| Thu Mar 26 | Kihara James | officer: PRINCIPAL ACCOUNTING OFFICER | Sell | 2,142 | $0.00 | 27,994 |
| Thu Mar 26 | Thompson Elizabeth H.Z. | officer: EVP, Head of Research & Dev | Sell | 3,435 | $21.47 | 3,280 |
| Fri Mar 20 | Poole Jonathan | director | Sell | 7,482 | $22.50 | 7,482 |
| Fri Mar 20 | Poole Jonathan | director | Sell | 4,218 | $0.00 | 4,218 |
| Fri Mar 20 | Poole Jonathan | director | Sell | 3,565 | $22.50 | 3,565 |
| Fri Mar 20 | Poole Jonathan | director | Sell | 2,010 | $0.00 | 2,010 |
| Fri Mar 20 | Poole Jonathan | Sell | 0 | $0.00 | 0 | |
| Tue Mar 10 | Schneyer Mark C. | officer: EVP, CHIEF FINANCIAL OFFICER | Sell | 90,691 | $22.16 | 90,691 |
| Tue Mar 10 | Rhodes Jennifer J | officer: EVP, CHIEF LEGAL OFFICER, SEC | Sell | 26,382 | $0.00 | 26,382 |
| Tue Mar 10 | Rhodes Jennifer J | officer: EVP, CHIEF LEGAL OFFICER, SEC | Sell | 90,691 | $22.16 | 90,691 |